KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) Return on Invested Capital (2016 - 2024)

Historic Return on Invested Capital for AbbVie (ABBV) over the last 13 years, with Q3 2025 value amounting to 8.67%.

  • AbbVie's Return on Invested Capital rose 79500.0% to 8.67% in Q3 2025 from the same period last year, while for Sep 2025 it was 8.67%, marking a year-over-year increase of 79500.0%. This contributed to the annual value of 0.15% for FY2024, which is 200.0% up from last year.
  • As of Q3 2025, AbbVie's Return on Invested Capital stood at 8.67%, which was up 79500.0% from 3.85% recorded in Q2 2025.
  • In the past 5 years, AbbVie's Return on Invested Capital registered a high of 8.67% during Q3 2025, and its lowest value of 0.23% during Q4 2023.
  • Moreover, its 5-year median value for Return on Invested Capital was 0.49% (2024), whereas its average is 1.09%.
  • In the last 5 years, AbbVie's Return on Invested Capital plummeted by -3700bps in 2022 and then soared by 79500bps in 2025.
  • Over the past 5 years, AbbVie's Return on Invested Capital (Quarter) stood at 0.3% in 2021, then increased by 1bps to 0.3% in 2022, then dropped by -24bps to 0.23% in 2023, then grew by 17bps to 0.27% in 2024, then surged by 3131bps to 8.67% in 2025.
  • Its Return on Invested Capital stands at 8.67% for Q3 2025, versus 3.85% for Q2 2025 and 0.31% for Q1 2025.